Literature DB >> 21357650

Radiographic regression of cranial meningioma in a NF2 patient treated by bevacizumab.

S Goutagny1, E Raymond2, O Sterkers3, J M Colombani4, M Kalamarides5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21357650     DOI： 10.1093/annonc/mdr012

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  11 in total

1.  Phase II study of mTORC1 inhibition by everolimus in neurofibromatosis type 2 patients with growing vestibular schwannomas.

Authors:  Stéphane Goutagny; Eric Raymond; Marina Esposito-Farese; Stéphanie Trunet; Christian Mawrin; Daniele Bernardeschi; Béatrice Larroque; Olivier Sterkers; Marco Giovannini; Michel Kalamarides
Journal:  J Neurooncol       Date:  2015-01-08       Impact factor: 4.130

2.  Description of selected characteristics of familial glioma patients - results from the Gliogene Consortium.

Authors:  Siegal Sadetzki; Revital Bruchim; Bernice Oberman; Georgina N Armstrong; Ching C Lau; Elizabeth B Claus; Jill S Barnholtz-Sloan; Dora Il'yasova; Joellen Schildkraut; Christoffer Johansen; Richard S Houlston; Sanjay Shete; Christopher I Amos; Jonine L Bernstein; Sara H Olson; Robert B Jenkins; Daniel Lachance; Nicholas A Vick; Ryan Merrell; Margaret Wrensch; Faith G Davis; Bridget J McCarthy; Rose Lai; Beatrice S Melin; Melissa L Bondy
Journal:  Eur J Cancer       Date:  2013-01-04       Impact factor: 9.162

Review 3.  Historical benchmarks for medical therapy trials in surgery- and radiation-refractory meningioma: a RANO review.

Authors:  Thomas Kaley; Igor Barani; Marc Chamberlain; Michael McDermott; Katherine Panageas; Jeffrey Raizer; Leland Rogers; David Schiff; Michael Vogelbaum; Damien Weber; Patrick Wen
Journal:  Neuro Oncol       Date:  2014-02-04       Impact factor: 12.300

Review 4.  Medical management of meningiomas.

Authors:  Wendy J Sherman; Jeff J Raizer
Journal:  CNS Oncol       Date:  2013-03

5.  Regression of Intracranial Meningiomas Following Treatment with Cabozantinib.

Authors:  Rupesh Kotecha; Raees Tonse; Haley Appel; Yazmin Odia; Ritesh R Kotecha; Guilherme Rabinowits; Minesh P Mehta
Journal:  Curr Oncol       Date:  2021-04-18       Impact factor: 3.677

6.  Neurofibromatosis 2011: a report of the Children's Tumor Foundation annual meeting.

Authors:  Michel Kalamarides; Maria T Acosta; Dusica Babovic-Vuksanovic; Olli Carpen; Karen Cichowski; D Gareth Evans; Filippo Giancotti; C Oliver Hanemann; David Ingram; Alison C Lloyd; Debra A Mayes; Ludwine Messiaen; Helen Morrison; Kathryn North; Roger Packer; Duojia Pan; Anat Stemmer-Rachamimov; Meena Upadhyaya; David Viskochil; Margret R Wallace; Kim Hunter-Schaedle; Nancy Ratner
Journal:  Acta Neuropathol       Date:  2011-11-16       Impact factor: 17.088

7.  Isolated Extracranial Intraosseous Metastasis of an Intracranial Meningioma following Bevacizumab Therapy: Case Report and Review of the Literature.

Authors:  Debraj Mukherjee; Jethro L Hu; Ray M Chu
Journal:  Asian J Neurosurg       Date:  2018 Jan-Mar

8.  Bevacizumab treatment for meningiomas in NF2: a retrospective analysis of 15 patients.

Authors:  Fabio P Nunes; Vanessa L Merker; Dominique Jennings; Paul A Caruso; Emmanuelle di Tomaso; Alona Muzikansky; Fred G Barker; Anat Stemmer-Rachamimov; Scott R Plotkin
Journal:  PLoS One       Date:  2013-03-21       Impact factor: 3.240

9.  Intratumoral and peritumoral post-irradiation changes, but not viable tumor tissue, may respond to bevacizumab in previously irradiated meningiomas.

Authors:  Motomasa Furuse; Naosuke Nonoguchi; Shinji Kawabata; Tomo Miyata; Taichiro Toho; Toshihiko Kuroiwa; Shin-Ichi Miyatake
Journal:  Radiat Oncol       Date:  2015-07-30       Impact factor: 3.481

Review 10.  Emerging Medical Treatments for Meningioma in the Molecular Era.

Authors:  Fares Nigim; Hiroaki Wakimoto; Ekkehard M Kasper; Linda Ackermans; Yasin Temel
Journal:  Biomedicines       Date:  2018-08-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.